SecBot SecBot
144 ·Filed Nov 9, 2026

UTHR

UNITED THERAPEUTICS Corp
NEUTRAL
Impact 2/10
Horizonimmediate Processed7d 7h ago SEC0001950047-26-010885
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

This is a small, routine sale by a director following an option exercise. No material signal for the stock. Monitor for any larger insider sales or changes in insider trading patterns.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1
Entry
$588.61
T+0 close · Nov 9, 2026 · via day close
Latest settled
+1.20%
T+1 · $595.66 · next T+5 in 7h
Vs SPY
−0.12%
α at T+1
Latest observation
−0.23%
T+4 · FF3 residual α
  1. T+0 · Nov 10 $588.61entry
  2. T+1 · 6d ago +1.20%α −0.12% · $595.66
  3. T+4 · todayOpen
  4. T+5 · in 7h Pending
  5. T+20 · in 22d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Director Christopher Patusky filed a Form 144 notice of intent to sell 1,210 shares of United Therapeutics Corp common stock, valued at approximately $701,800 based on the filing. The shares were acquired through a stock option exercise on the same date. This is a routine insider sale by a director, representing a small fraction of the company's $24.1B market cap.

Key Facts

  • Director Christopher Patusky filed Form 144 to sell 1,210 shares of United Therapeutics Corp common stock.
  • The approximate market value of the proposed sale is $701,800.
  • Shares were acquired via a stock option exercise on November 9, 2026.
  • The sale is planned for execution on November 9, 2026, through Morgan Stanley Smith Barney LLC.
  • The proposed sale represents about 0.003% of the company's $24.1B market cap.

Financial Impact

Proposed sale of 1,210 shares worth approximately $701,800, a de minimis amount relative to the company's $24.1B market cap.

dilution

Risk Factors

  • Form 144 is an intent to sell; the actual sale may not occur.
  • Insider sales can sometimes precede negative news, but the size here is negligible.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
82% bullish (22 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-010885
Document: 0001950047-26-010885-index.html0001950047-26-010885
Document: 0001950047-26-010885.txt0001950047-26-010885

Track record

123 reports on UTHR

Performance horizon

4 of 9 bullish or bearish reports moved the stock their way by T+5. Best: +10.30% at T+20 after the Oct 14, 2026 report. 5 of 9 went positive at some point.

Filters
  1. Nov 16, 2026today Insider Cluster Neutral 3/10 Entry $587.88 Now $587.88 +0.00% settles Nov 24
  2. Nov 13, 20263d ago Insider Cluster Bearish 4/10 Entry $597.50 Now $587.88 +1.61% settles Nov 23
  3. Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $591.17 Now $587.88 −0.56% settles Nov 20
  4. Nov 10, 20266d ago Insider Cluster Neutral 2/10 Entry $595.66 Now $587.88 −1.31% settles Nov 18
  5. Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
  6. Nov 9, 20267d ago 144 Neutral 2/10 Viewing Entry $588.61 Now $587.88 −0.12% settles Nov 17
  7. Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $582.46 to $587.88 Now $587.88 +0.93% ▲ +0.93% +2.62% vs SPY
  8. Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
  9. Nov 5, 202611d ago 144 Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
  10. Nov 4, 202612d ago SC 13G/A Neutral 2/10 Entry $565.72 to $593.31 Now $587.88 +3.92% ▲ +4.88% +1.59% vs SPY
Showing 10 of 123

US Market Status

Market Closed · Opens in 9h 4m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 9, 2026